Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | -0.43% | -3.77% | -0.43% |
15/05 | Compugen Names David Silberman CFO | MT |
09/05 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.43% | 9.34Cr | |
+64.23% | 6.26TCr | |
-2.31% | 4.12TCr | |
+44.36% | 4.03TCr | |
-8.29% | 2.79TCr | |
+11.97% | 2.62TCr | |
-21.16% | 1.91TCr | |
+7.54% | 1.31TCr | |
+27.17% | 1.21TCr | |
+25.72% | 1.23TCr |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Transcript : Oramed Pharmaceuticals Inc. - Special Call